3906 Williams et al.
Macromolecules, Vol. 36, No. 11, 2003
0 °C for 2 h and at RT for 18 h. After concentration, the product
was purified by gradient LPLC with CH2Cl2:ethyl acetate (1:
0-1:1) as the eluent [yield: 5.40 g, (74.5%)]; oil. EI-MS: 732,
17H), 1.94 (m, 10H), 1.75 (m, 13H) (ratio 5:1) (theoretical ratio
4:1). HPLC (acetonitrile) 2.78 min; TLC Rf ) 0.48 (60% CH2Cl2:
ethyl acetate).
1
554, 510, 178, 121 m/z. H NMR (CDCl3) δ: 7.78 (d, 2H), 7.63
p-Meth oxyben zyl-P r otected Bu tylen e Glu ta r a te Oc-
ta m er (9B). In a round-bottom flask, 3.15 g (2.93 mmol) of
orthogonally protected butylene glutarate octamer37 (9) was
stirred in a solution of 5.0% TEA in 50 mL of CH2Cl2 at RT
for 4 h. The volatile components were removed by rotary
evaporation and dried overnight. The crude product was
redissolved in CH2Cl2, filtered, and then purified by gradient
LPLC with CH2Cl2:ethyl acetate (9:1-0:1) as the eluent.
Impure LPLC column fractions were repurified using FLC
(80% CH2Cl2:ethyl acetate) [yield: 2.04 g (79.1%)]; oil. MALDI-
TOF-MS: 921, 905 m/z. 1H NMR (CDCl3) δ: 7.28 (d, 2H), 6.88
(d, 2H), 5.04 (s, 2H), 4.10 (t, 16H), 3.80 (s, 3H), 2.37 (m, 18H),
1.94 (t, 12H), 1.68 (m, 15H) (ratio 6:1) (theoretical ratio 4:1).
HPLC (acetonitrile) 3.06 min; TLC Rf ) 0.46 (60% CH2Cl2:
ethyl acetate).
(d, 2H), 7.44 (t, 2H), 7.33 (t, 2H), 7.29 (d, 2H), 6.90 (d, 2H),
5.05 (s, 2H), 4.41 (t, 2H), 4.29 (t, 1H), 4.23 (t, 2H), 4.10 (t, 4H),
3.80 (s, 3H), 2.39 (m, 9H), 1.91 (m, 5H), 1.78 (t, 5H), 1.70 (t,
5H) (ratio 2.5:1) (theoretical ratio 2:1). HPLC (acetonitrile) 2.91
min; TLC Rf ) 0.78 (80% CH2Cl2:ethyl acetate).
F MOC-P r otected Bu tylen e Glu ta r a te Tetr a m er (8A).
In a round-bottom flask, 5.2 g (7.10 mmol) of orthogonally
protected butylene glutarate tetramer37 (8) was stirred in a
200 mL solution of 5% TFA in CH2Cl2 for 2 h. The reaction
mixture was extracted 3 × 200 mL of water, and the organic
fraction was rotary evaporated and dried overnight. The crude
product was purified by gradient LPLC with CH2Cl2:ethyl
acetate (1:0-0:1) as the eluent [yield: 3.92 g, (90.1%)]; oil. EI-
MS: 612, 178, 165 m/z. 1H NMR (CDCl3) δ: 7.78 (d, 2H), 7.63
(d, 2H), 7.44 (t, 2H), 7.33 (t, 2H), 4.41 (t, 2H), 4.28 (t, 1H),
4.23 (t, 2H), 4.10 (t, 6H), 2.39 (m, 9H), 1.93 (m, 6H), 1.78 (t,
5H), 1.70 (t, 6H) ppm (ratio 3:1) (theoretical ratio 2:1). HPLC
(acetonitrile) 2.77 min; TLC Rf ) 0.26 (80% CH2Cl2:ethyl
acetate).
p-Meth oxyben zyl-P r otected Bu tylen e Glu ta r a te Tet-
r a m er (8B). In a round-bottom flask, 4.30 g (5.90 mmol) of
orthogonally protected butylene glutarate tetramer37 (8) was
stirred in a 100 mL 5% w/w solution of TEA in CH2Cl2 at RT
for 4 h. The volatile components were removed using rotary
evaporation, and the crude product was dried overnight, then
dissolved in CH2Cl2, and filtered, followed by purification by
gradient LPLC with CH2Cl2:ethyl acetate (1:0-0:1) as the
eluent [yield: 2.65 g (88.3%)]; oil. EI-MS: 510, 373, 121 m/z.
1H NMR (CDCl3) δ: 7.29 (d, 2H), 6.90 (d, 2H), 5.06 (s, 2H),
4.13 (t, 5H), 3.82 (s, 3H), 3.69 (t, 2H), 2.39 (m, 9H), 1.96 (m,
5H), 1.69 (t, 11H) (ratio 2.5:1) (theoretical ratio 2:1). HPLC
(acetonitrile) 2.84; TLC Rf ) 0.18 (80% CH2Cl2:ethyl acetate).
Bu tylen e Glu ta r a te Tetr a m er (8C). In an 50 mL Erlen-
meyer flask, 50 mg (0.082 mmol) of FMOC-protected butylene
glutarate tetramer (8A) was stirred with 410 mg (4.1 mmol,
50 equiv) of TEA in 30 mL of CH2Cl2 for 4 h. The solvent and
TEA were removed by rotary evaporation followed by vacuum-
drying, and the pure product was isolated by filtration of a
CH2Cl2 solution and washing with hexanes [yield: 27.7 mg
(86.9%)]; oil. CI-MS 391. ESI-MS, LSI-MS, and MALDI-TOF-
MS 413 m/z. 1H NMR (CDCl3) δ: 4.13 (t, 6H), 3.69 (t, 2H),
2.38 (m, 8H), 1.95 (m, 6H), 1.70 (s, 11H) (ratio 3:1) (theoretical
ratio 2:1). HPLC (acetonitrile) 3.12 min.
Bu tylen e Glu ta r a te Octa m er (9C). In an 50 mL Erlen-
meyer flask, 75 mg (0.085 mmol) of FMOC-protected butylene
glutarate octamer (9A) was stirred with 30 mL of 5% TEA in
CH2Cl2 at RT for 4 h and then extracted with 3 × 30 mL of
H2O. The organic solvent was removed by rotary evaporation,
and the crude product was then vacuum-dried (48 h) and
isolated by filtration of a CH2Cl2 solution followed by precipi-
tation with hexanes [yield: 55.3 mg (85.3%)]; waxy solid.
1
MALDI-TOF-MS 807, 785 m/z. H NMR (CDCl3) δ: 4.13 (t,
16H), 3.69 (t, 2H), 2.38 (m, 17H), 1.95 (m, 10H), 1.70 (s, 17H)
(ratio 5:1) (theoretical ratio 4:1); HPLC (acetonitrile) 3.60 min.
Or t h ogon a lly P r ot ect ed Bu t ylen e Glu t a r a t e 16-m er
(10). In a round-bottom flask, 2.27 g (2.31 mmol) of FMOC-
protected butylene glutarate octamer (9A), 2.04 g (2.31 mmol)
of p-methoxybenzyl-protected butylene glutarate octamer (9B),
and 0.06 g (0.47 mmol) of DMAP were mixed in 100 mL of
CH2Cl2 at 0 °C. EDCI (0.45 g) (2.55 mmol) was added, and
the reaction mixture was stirred at 0 °C for 2 h and at RT for
18 h. The mixture was then reduced to 10 mL, and the crude
product was purified by gradient LPLC with CH2Cl2:ethyl
acetate (8:1-5:1) as the eluent. Impure fractions were re-
purified by FLC with CH2Cl2:ethyl acetate (7.5:1) as the eluent
[yield: 3.42 g (80.0%)]; oil. MALDI-TOF-MS: 1888, 1872 m/z.
1H NMR (CDCl3) δ: 7.77 (d, 2H), 7.61 (d, 2H), 7.39 (t, 2H),
7.33 (t, 2H), 7.28 (d,2H), 6.88 (d, 2H), 5.04 (s, 2H), 4.34 (d,
2H), 4.23 (t,1H), 4.18 (t, 2H), 4.09 (t, 38H), 3.78 (s, 3H), 2.35
(m,40H), 1.91 (t, 22H), 1.76 (s, 6H), 1.66 (s, 30H) (ratio 11:1)
(theoretical ratio 8:1). HPLC (acetonitrile) 3.23 min; TLC Rf
) 0.73 (60% CH2Cl2:ethyl acetate).
Or th ogon a lly P r otected Bu tylen e Glu ta r a te Octa m er
(9). In a round-bottom flask, 3.20 g (5.20 mmol) of FMOC-
protected butylene glutarate tetramer (8A), 2.65 g (5.20 mmol)
of p-methoxybenzyl-protected butylene glutarate tetramer
(8B), and 0.13 g (1.0 mmol) of DMAP were stirred at 0 °C.
1.10 g of EDCI (5.72 mmol) was added, and the reaction
mixture was stirred at 0 °C for 2 h and at RT for 18 h. The
solvent was reduced, and the crude product was purified by
gradient LPLC using CH2Cl2:ethyl acetate (1:0-1:1) [yield:
4.60 g (80.1%)]; oil. MALDI-TOF-MS: 1143, 1127 m/z. 1H
NMR (CDCl3) δ: 7.78 (d, 2H), 7.61 (d, 2H), 7.40 (t, 2H), 7.33
(d, 2H), 7.29 (d, 2H), 6.88 (d, 2H), 5.04 (s, 2H), 4.40 (t, 2H),
4.23 (t, 1H), 4.17 (t,2H), 4.11 (t, 11H), 3.79 (s, 3H), 2.36 (m,
17H), 1.93 (t, 10H), 1.78 (t, 8H), 1.67 (t, 7H) (ratio 5:1)
(theoretical ratio 4:1). HPLC (acetonitrile) 3.04 min; TLC Rf
) 0.54 (80% CH2Cl2:ethyl acetate).
F MOC-P r otected Bu tylen e Glu ta r a te Octa m er (9A). In
a round-bottom flask, 4.05 g (3.75 mmol) of orthogonally
protected butylene glutarate octamer37 (9) was stirred for 2 h
in 100 mL of 5% w/w TFA in CH2Cl2. The reaction mixture
was extracted with 3 × 100 mL of water and the organic
fraction rotary-evaporated and vacuum-dried. The crude prod-
uct was purified by gradient LPLC with CH2Cl2:ethyl acetate
(1:0-0:1) as the eluent. Impure LPLC column fractions were
repurified using FLC (80% CH2Cl2:ethyl acetate) [yield: 2.72
g (75.1%)]; oil. MALDI-TOF-MS: 1023, 1007 m/z. 1H NMR
(CDCl3) δ: 7.76 (d, 2H), 7.61 (d, 2H), 7.46 (t, 2H), 7.32 (t, 2H),
4.40 (d, 2H), 4.28 (t, 1H), 4.22 (t, 2H), 4.09 (t, 14H), 2.37 (p,
F MOC-P r otected Bu tylen e Glu ta r a te 16-m er (10A). In
a round-bottom flask, 1.50 g (0.811 mmol) of orthogonally
protected butylene glutarate 16-mer (10) was stirred with 50
mL of 5% w/w TFA in CH2Cl2 at RT for 2 h. The reaction
mixture was extracted 3 × 50 mL of water and the organic
fraction was dried prior to purification of the crude product
by gradient LPLC with CH2Cl2:ethyl acetate (7:1-0:1) as the
eluent [yield: 1.24 g (88.6%)]; oil. MALDI-TOF-MS: 1768,
1
1752 m/z. H NMR (CDCl3) δ: 7.78 (d, 2H), 7.62 (d, 2H), 7.40
(t, 2H), 7.33 (t, 2H), 4.40 (d, 2H), 4.23 (t, 1H), 4.19(t), 4.10 (t,
38H), 2.35 (m, 42H), 1.92 (m, 24H), 1.78 (t, 7H), 1.73 (t, 29H)
(ratio 12:1) (theoretical ratio 8:1). HPLC (acetonitrile) 2.97 min;
TLC Rf ) 0.42 (60% CH2Cl2:ethyl acetate).
p-Meth oxyben zyl-P r otected Bu tylen e Glu ta r a te 16-
m er (10B). In a round-bottom flask, 1.45 g (0.785 mmol) of
orthogonally protected butylene glutarate 16-mer37 (10) was
stirred with 4.0 g of TEA (50 equiv) in 50 mL of CH2Cl2 at RT
for 4 h. The reaction mixture was rotary-evaporated and dried
overnight to remove volatile components. The crude product
was dissolved in CH2Cl2, filtered, and then purified by gradient
LPLC with CH2Cl2:ethyl acetate (8:1-5:1) as the eluent.
Impure fractions were repurified by FLC with CH2Cl2 (6:1) as
the eluent [yield: 1.14 g 89.1%)]; oil. MALDI-TOF-MS: 1666,
1
1650 m/z. H NMR (CDCl3) δ: 7.28 (d, 2H), 6.87 (d, 2H), 5.04
(s, 2H), 4.09 (t, 39H), 3.79 (s, 3H), 3.65 (t, 2H), 2.35 (m, 42H),
1.92 (m, 22H), 1.64 (s, 36H) (ratio 11:1) (theoretical ratio 8:1);
HPLC (acetonitrile) 2.72 min; TLC Rf ) 0.48 (60% CH2Cl2:
ethyl acetate).